Inhibition of both Anoctamin 1 and Transient Receptor Potential Vanilloid 4 Channels is critical for attenuation of perspiration

The human body maintains a delicate balance with its environment, constantly adjusting to keep its internal temperature stable. When the air grows warm, the skin responds by releasing moisture, a process known as sweating. This is not merely a wetting of the surface; it is a sophisticated biological mechanism driven by tiny factories called sweat glands. Inside these glands, specific cells act as gatekeepers, opening channels to let charged particles flow in and out. This movement of particles pulls water with it, creating the sweat that cools us down. For decades, the most common way to stop this process has been to physically block the exit pipes of these glands using aluminum salts, which form a plug to prevent moisture from escaping. However, this method is a blunt instrument that does not address the underlying biological signals telling the body to sweat in the first place. Scientists have long sought a way to turn off the faucet rather than just capping the spout, focusing their attention on the molecular switches that control the flow of water.

Two specific proteins have emerged as central players in this molecular drama. One is a channel that allows calcium to enter the cell, acting like a sensor that detects warmth. The other is a channel that lets chloride ions escape, which is the step that actually pulls the water out. Recent research suggests these two proteins do not work in isolation; they form a partnership, a complex unit where the calcium sensor triggers the chloride channel to open. If this partnership is essential for sweating, then stopping just one part of the team might not be enough to halt the process. This idea led researchers to investigate whether a substance that could disrupt both partners simultaneously would be a more effective way to stop perspiration.

A team of scientists, led by researchers at Nagoya City University and colleagues from Ikeda Mohando Co., Ltd., set out to test this hypothesis. They began by examining a substance called l-menthol, which they had previously known could reduce sweating. Their initial goal was to see if this compound could interfere with the calcium-sensing protein. Using specialized equipment to measure electrical currents in cells, they found that l-menthol indeed blocked the activity of both the calcium sensor and the chloride channel. This discovery confirmed that inhibiting both partners of the protein complex was a viable path forward. However, since l-menthol is primarily known for its cooling sensation, the team needed to find a different compound that could achieve the same dual inhibition without the strong cooling effect, making it suitable for use as a daily antiperspirant.

The researchers turned their attention to crotamiton, a medication already in use for decades to relieve itching. It was known to block the calcium-sensing protein, but its effect on the chloride channel was unknown. The team tested crotamiton on human cells in a laboratory setting and discovered that it successfully blocked the chloride channel as well. This meant that crotamiton had the unique ability to shut down both sides of the sweating mechanism. To see if this worked in a living system, they moved to experiments with mice. They applied crotamiton to the footpads of the animals and then stimulated the sweat glands with a chemical that normally triggers heavy perspiration. The results were striking: the treated footpads remained dry, showing almost no signs of sweat, while untreated paws became visibly wet.

Crucially, the study also tested what happened when only one part of the protein team was blocked. The researchers applied a drug that blocked only the calcium sensor and another that blocked only the chloride channel. Neither of these single-target treatments was enough to stop the sweating in the mice. It was only when both targets were blocked simultaneously that the sweat production ceased. This finding reinforced the idea that the two proteins work together as a unit, and that effective antiperspirants must target both to be truly successful.

The team then took their findings to human volunteers to see if the results held true in people. They recruited subjects and applied a ten percent solution of crotamiton to their upper arms. After allowing the solution to dry, the volunteers were placed in a warm, humid room designed to trigger natural sweating. The researchers measured the amount of sweat produced over a ten-minute period. The data showed a clear difference: the skin treated with crotamiton produced significantly less sweat than the untreated skin. The reduction was substantial, with the treated areas producing less than half the amount of moisture compared to the control areas. This confirmed that the dual-blocking mechanism observed in the lab and in mice translated effectively to human skin.

The study also looked at the skin itself to understand why this approach works. By examining samples of human sweat glands, the researchers confirmed that the two proteins they were targeting are found together in the same cells, sitting side by side in the secretory units of the gland. This physical proximity supports the theory that they function as a coordinated team. The researchers noted that while other treatments exist, such as drugs that target a different water channel, those have not shown consistent success in clinical trials for excessive sweating. In contrast, the approach of blocking both the calcium sensor and the chloride channel appears to be a robust strategy.

Crotamiton is already approved for use on human skin as a treatment for itching, which suggests it has a known safety profile. The concentration used in these experiments was the same as that used in standard medical treatments for skin irritation, indicating that the method does not require new or potentially dangerous chemicals. The study concludes that targeting both proteins simultaneously offers a promising new direction for developing antiperspirants that work by stopping the biological signal to sweat, rather than just plugging the hole. This represents a shift from physical blockage to molecular regulation, potentially offering a more effective solution for those who suffer from excessive sweating. The work suggests that the future of sweat control may lie in understanding and interrupting the specific partnership between these two proteins, turning off the body's cooling system at its source.